- Home
- MRNA vs SWK Comparison
MRNA vs SWK Comparison
Compare MRNA & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | SWK |
|---|---|---|
| Founded | 2010 | 1843 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 11.1B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRNA | SWK |
|---|---|---|
| Price | $27.57 | $72.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $33.91 | ★ $92.25 |
| AVG Volume (30 Days) | ★ 9.9M | 1.5M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.90 |
| Revenue | $2,232,000,000.00 | ★ $15,166,300,000.00 |
| Revenue This Year | N/A | $0.05 |
| Revenue Next Year | $0.77 | $3.01 |
| P/E Ratio | ★ N/A | $25.02 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.28 | $53.91 |
| 52 Week High | $48.92 | $91.06 |
Technical Indicators
Market Signals| Indicator | MRNA | SWK |
|---|---|---|
| Relative Strength Index (RSI) | 60.85 | 60.67 |
| Support Level | $23.92 | $69.27 |
| Resistance Level | $26.00 | $72.20 |
| Average True Range (ATR) | 1.29 | 2.14 |
| MACD | 0.32 | 0.82 |
| Stochastic Oscillator | 99.82 | 91.22 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.